Welcome To ChemAnalyst
Para Aminophenol in China firmed sharply in March as upstream feedstock inflation and export restocking tightened spot supply. Early gains were driven by higher feedstock costs, while mid-March environmental inspections reduced operating days for smaller units, trimming available volumes. Demand from dye-stuff producers remained steady, and pharmaceutical formulators in India and Brazil accelerated restocking, sustaining order momentum for April shipments. Chinese exporters kept margins intact and held firm offers despite tighter supply. The tone remained constructive amid constrained supply and resilient overseas demand. Demand dynamics were uneven; the pharmaceutical sector stayed robust on paracetamol intermediates and restocking ahead of the northern-hemisphere allergy and flu cycle. Upstream costs rose, with phenol remaining a major feedstock share, pressuring export pricing. Supply-side factors kept inventories tight and logistics orderly. Outlook points to further upside in April and May before a June pullback. Upside risks include ongoing restocking and tighter benzene flows.
Para Aminophenol prices in China rose sharply throughout March, supported by strong upstream cost pressures and resilient export demand that tightened spot availability. Early in the month, Para Aminophenol markets turned bullish as rising Benzene and Phenol values increased production costs, while reduced operating rates at smaller reduction units further constrained supply. Para Aminophenol availability was additionally impacted by fewer operating days at select facilities, limiting prompt cargoes. Meanwhile, Para Aminophenol demand remained firm as dye manufacturers maintained steady procurement and pharmaceutical buyers accelerated restocking. Increased overseas demand from India and Brazil sustained order flows, allowing Para Aminophenol exporters to defend higher offers and maintain strong pricing discipline into April shipments.
Demand dynamics for Para Aminophenol were mixed but overall supportive, reinforcing the upward price movement. The pharmaceutical sector remained the key driver, supported by strong demand for paracetamol intermediates and formulation restocking ahead...
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.
